"Washington's largest lobby, the pharmaceutical industry, racked up another banner year on Capitol Hill in 2007, backed by a record $168 million lobbying effort," reports M. Asif Ismail.
"It's hard to take the airlines seriously when they try to play the pity card with consumers," opines Advertising Age. The trade publication's biting editorial comes in response to a public relations push by the Air Transport Association of America (ATA).
On July 15, "an unlikely alliance" rallied in Washington DC to "stop the war on the poor" by increasing U.S. domestic oil and gas production.
The following article appeared in the June 2008 issue of The Progressive magazine.
The nuclear power industry is seeing its fortunes rise. "Seventeen entities developing license applications for up to thirty-one new [nuclear] reactors did not just happen," boasted Frank "Skip" Bowman. "It has been carefully planned."
Bowman heads the Nuclear Energy Institute (NEI), the main lobbying group for the industry. His remarks (PDF), at a February gathering of more than 100 Wall Street analysts, were part of a presentation on "reasoned expectations for new nuclear plant construction."
Bowman knew it was important to impress his audience of wary potential investors. "We are where we are today because this industry started many years ago on a systematic program to identify what went wrong the last time," he said, "and develop ways to eliminate or manage those risks."
The American Association of Public Health Physicians (AAPHP) has published an updated analysis of H.R. 1108, the massive bill currently under consideration by Congress that would give the U.S. Food and Drug Administration authority to regulate tobacco products. AAPHP concludes, "This bill is a scam.
"The State of Nevada faces almost a billion dollar budget shortfall," reports Edward Lawrence. "The Nuclear Energy Institute says there is a solution ... but it comes with one very large string attached" -- that the state end opposition to the proposed nuclear waste repository at Yucca Mountain.